CAS RN: 5625-90-1
N,N’-Dimorpholinomethane
Product Availability
Choose a grade to view its available package options.
2 package records 2 with current stock 1 grade group
Grade
98% (2)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20251201
1g
In stock
Shanghai, Shandong Inquiry
Batchno.20251211
5g
In stock
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 100g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 5625-90-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
100g
≥97%
0
Out of Stock
Hong Kong
Inquiry
5625-90-1 / 4-(morpholin-4-ylmethyl)morpholine
Standard CAS: 5625-90-1
Multi CAS: No
Basic Information
copy
CAS
5625-90-1 copy
Multi CAS
No copy
Molecular Formula
C9H18N2O2 copy
Molecular Weight
186.250000 copy
Exact Mass
186.136828 copy
InChI
InChI=1S/C9H18N2O2/c1-5-12-6-2-10(1)9-11-3-7-13-8-4-11/h1-9H2 copy
InChIKey
MIFZZKZNMWTHJK-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Fraction Csp3
1 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
Molar refractivity
49.65 copy
TPSA
24.94 copy
LogP / Solubility
WLOGP
-0.39 copy
MLOGP
-0.35 copy
XLogP3
-0.3 copy
Consensus LogP
-0.35 copy
Log S (ESOL)
-0.62 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-0.8 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-0.79 copy
Class (SILICOS-IT)
Very soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.13 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy